(Q44423328)

2 December 2017

Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer (English)

1 reference

2 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

29 December 2023

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

29 December 2023

author name string

Celeste Lindley

7

1 reference

2 December 2017

Stacy S. Shord

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721761

29 December 2023

Stephanie R. Faucette

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721761

29 December 2023

Heidi H. Gillenwater

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721761

29 December 2023

Scott L. Pescatore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721761

29 December 2023

Roy L. Hawke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721761

29 December 2023

Mark A. Socinski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12721761

29 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12721761

29 December 2023

publication date

13 March 2003

1 reference

Cancer Chemotherapy and Pharmacology

2 December 2017

1 reference

2 December 2017

51

1 reference

2 December 2017

328-336

1 reference

2 December 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-002-0560-1

2 December 2017

0 references

cites work

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

29 December 2023

2

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer

29 December 2023

3

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

29 December 2023

6

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine

29 December 2023

10

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study

29 December 2023

11

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

29 December 2023

Molecular Pharmacology

13

42

518

Shewach

1992

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Validated assays for the determination of gemcitabine in human plasma and urine using high-performance liquid chromatography with ultraviolet detection

29 December 2023

14

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer

29 December 2023

15

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase

29 December 2023

22

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

29 December 2023

23

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Cytosine arabinoside influx and nucleoside transport sites in acute leukemia

29 December 2023

25

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

29 December 2023

26

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.

29 December 2023

29

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine

29 December 2023

30

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides

29 December 2023

31

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer

29 December 2023

32

1 reference

https://api.crossref.org/works/10.1007/S00280-002-0560-1

29 December 2023

Identifiers

0 references

1 reference